Bronchospasm
{{}} |
WikiDoc Resources for Bronchospasm |
Articles |
---|
Most recent articles on Bronchospasm Most cited articles on Bronchospasm |
Media |
Powerpoint slides on Bronchospasm |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Bronchospasm at Clinical Trials.gov Clinical Trials on Bronchospasm at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Bronchospasm
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Bronchospasm Discussion groups on Bronchospasm Patient Handouts on Bronchospasm Directions to Hospitals Treating Bronchospasm Risk calculators and risk factors for Bronchospasm
|
Healthcare Provider Resources |
Causes & Risk Factors for Bronchospasm |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate-editor-in-chief: Areej Tariq
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Bronchospasm is a difficulty in breathing caused by a sudden constriction of the muscles in the walls of the bronchioles. It is caused by the release (degranulation) of substances from mast cells or basophils under the influence of anaphylatoxins.
Bronchospasm appears as the feature of asthma, chronic bronchitis, anaphylaxis, and as a possible side-effect of the drug Pilocarpine (which is used to treat illness resulting from the ingestion of deadly nightshade as well as other things). The overactivity of the bronchioles' muscle is a result of exposure to a stimulus which under normal circumstances would cause little or no response. The resulting constriction and inflammation causes a narrowing of the airways and an increase in mucous production; this reduces the amount of oxygen that is available to the individual causing breathlessness, coughing and hypoxia (that can cause cyanosis).
Differential diagnosis of the causes of Bronchospasm
- 5-Hydroxyindoleacetic acid
- Abciximab (patient information)
- Acetylsalicylic acid
- Alemtuzumab
- Allergic bronchopulmonary aspergillosis
- Anaphylatoxin
- Anaphylaxis
- Aspirin
- Atenolol
- Atracurium
- Beta-blockers
- Betaxolol
- Bronchial challenge test
- Chronic Stable Angina Diagnosis
- Chronic Stable Angina Treatment
- CMR Imaging
- Cocaine
- Colistin
- Ddx:Acidosis
- Diclofenac
- Exercise Stress Testing
- Formoterol (patient information)
- Hydrogen sulfide
- Hydroxyethyl starch
- Hypomagnesemia
- Ibuprofen
- Indomethacin
- Ketamine
- Ketorolac
- Major basic protein
- Monosodium glutamate
- Nadolol
- Nitrazepam
- Non-steroidal anti-inflammatory drug
- PCI Complications: Renal Failure
- Pentamidine
- Propafenone
- Rapacuronium
- Respiratory Failure
- Salmeterol oral inhalation (patient information)
- Schistosoma mansoni
- Scombroid
- Shock (medical)
- ST Elevation Myocardial Infarction Aspirin Therapy
- ST Elevation Myocardial Infarction Beta Blocker Therapy
- Tetrodotoxin
- Timolol
- Zanamivir